A share price of Tenax Therapeutics Inc [TENX] is currently trading at $12.19, up 1.58%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The TENX shares have gain 1.92% over the last week, with a monthly amount glided 34.40%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Tenax Therapeutics Inc [NASDAQ: TENX] stock has seen the most recent analyst activity on September 08, 2025, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $20. Previously, Leerink Partners started tracking the stock with Outperform rating on October 24, 2024, and set its price target to $16. On October 14, 2024, Guggenheim initiated with a Buy rating and assigned a price target of $16 on the stock. William Blair started tracking the stock assigning a Outperform rating. Ladenburg Thalmann upgraded its rating to a Buy. MLV & Co started tracking with a Buy rating for this stock on December 16, 2014, and assigned it a price target of $7. In a note dated November 18, 2014, WallachBeth initiated an Buy rating and provided a target price of $12 on this stock.
Tenax Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $4.63 and $14.22. Currently, Wall Street analysts expect the stock to reach $22.5 within the next 12 months. Tenax Therapeutics Inc [NASDAQ: TENX] shares were valued at $12.19 at the most recent close of the market. An investor can expect a potential return of 84.58% based on the average TENX price forecast.
Analyzing the TENX fundamentals
Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at -25102.17%, Pretax Profit Margin comes in at -15741.24%, and Net Profit Margin reading is -15741.24%. To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -0.31 and Total Capital is -0.49.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.91 points at the first support level, and at 11.62 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.41, and for the 2nd resistance point, it is at 12.62.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Tenax Therapeutics Inc [NASDAQ:TENX] is 15.58. Further, the Quick Ratio stands at 15.58, while the Cash Ratio is 41.73.
Transactions by insiders
Recent insider trading involved Rich Stuart, Chief Medical Officer, that happened on Dec 09 ’25 when 2500.0 shares were purchased. Chief Medical Officer, Rich Stuart completed a deal on Dec 08 ’25 to buy 2500.0 shares. Meanwhile, Chief Medical Officer Rich Stuart bought 2500.0 shares on Dec 04 ’25.
